InvestorsHub Logo
Followers 3421
Posts 32269
Boards Moderated 1
Alias Born 07/08/2006

Re: $heff post# 71907

Thursday, 09/19/2013 9:42:32 AM

Thursday, September 19, 2013 9:42:32 AM

Post# of 97237
CPRX..$2.89..I see any pullback being bought here. There is a 20.8% short position on the stock. This stock has catalysts in October and Q4. They also have the breakthrough designation. Shorts trying to put a lid on this are having a hard time. 2 days to cover a 21% short position is not very many days thus the sharp increases in price the past few days as we move closer to the catalysts.



Data Monitoring Committee
• DMC charter includes analyses of unblinded safety and
efficacy data
– Safeguard interests of study participants
– Assess the continuing safety & efficacy
• i.e. benefit of participation continues to outweigh risks
– Provide recommendations for conduct of study
– Provide recommendations for continuing or stopping study
Observations and recommendations from latest meeting
(03/25/13)
– To continue the trial as planned and without changes to the
protocol
– To continue encouraging greater enrollment rate by adding sites
• Next scheduled meeting October, 2013

Sheff's Station...All Aboard...Sign Up Here!

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.